With a shortage of new tuberculosis drugs in the pipeline, a software tool can predict how current drugs–including unlikely candidates — can be combined in new ways to create more effective treatments.
Click here for original story, How an AI solution can design new tuberculosis drug regimens
Source: ScienceDaily